Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

The Journal of clinical investigation ·Vol. 103 ·No. 9 ·1999-05-00 ·Pages 1231-6

Isner JM, Asahara T

Abstract

暂无摘要

MeSH Terms

Animals Endothelial Growth Factors/physiology,therapeutic use Humans Ischemia/drug therapy Lymphokines/physiology,therapeutic use Neovascularization, Physiologic Phenotype Recombinant Proteins/therapeutic use Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors

Chemicals

Endothelial Growth Factors Lymphokines Recombinant Proteins Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Isner J M

Tufts University School of Medicine, and the Divisions of Vascular Medicine and Biomedical Research, St. Elizabeth's Medical Center, Boston, Massachusetts 02135, [email protected]

Asahara T

References (28)

28 references, click to expand

Tumor angiogenesis: therapeutic implications.
N Engl J Med. 1971 Nov 18;285(21):1182-6 PMID: 4938153
Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice.
Circulation. 1999 Jun 22;99(24):3188-98 PMID: 10377084
Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression.
Circulation. 1994 Feb;89(2):785-92 PMID: 8313567
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.
J Clin Invest. 1994 Feb;93(2):662-70 PMID: 7509344
Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells.
J Biol Chem. 1995 Dec 29;270(52):31189-95 PMID: 8537383
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
J Clin Invest. 1996 Jan 15;97(2):469-76 PMID: 8567969
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.
Lancet. 1996 Aug 10;348(9024):370-4 PMID: 8709735
The effect of age on the transendothelial migration of human T lymphocytes.
Scand J Immunol. 1996 Nov;44(5):530-4 PMID: 8947606
Angiogenesis in ischemic heart disease.
Nat Med. 1997 Feb;3(2):158-64 PMID: 9018233
Isolation of putative progenitor endothelial cells for angiogenesis.
Science. 1997 Feb 14;275(5302):964-7 PMID: 9020076
Circulating activated endothelial cells in sickle cell anemia.
N Engl J Med. 1997 Nov 27;337(22):1584-90 PMID: 9371854
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.
J Clin Invest. 1998 Jan 1;101(1):40-50 PMID: 9421464
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.
J Thorac Cardiovasc Surg. 1998 Jan;115(1):168-76; discussion 176-7 PMID: 9451061
Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.
Circulation. 1998 Feb 24;97(7):645-50 PMID: 9495299
Isolation and characterization of endothelial progenitor cells from mouse embryos.
Development. 1998 Apr;125(8):1457-68 PMID: 9502726
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.
Circulation. 1998 Mar 31;97(12):1114-23 PMID: 9537336
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
J Clin Invest. 1998 Jun 1;101(11):2567-78 PMID: 9616228
Evidence for circulating bone marrow-derived endothelial cells.
Blood. 1998 Jul 15;92(2):362-7 PMID: 9657732
Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Circ Res. 1998 Oct 19;83(8):832-40 PMID: 9776730
Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
J Biol Chem. 1998 Nov 6;273(45):29979-85 PMID: 9792718
VEGF gene delivery to muscle: potential role for vasculogenesis in adults.
Mol Cell. 1998 Nov;2(5):549-58 PMID: 9844628
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
J Vasc Surg. 1998 Dec;28(6):964-73; discussion 73-5 PMID: 9845647
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.
Circulation. 1998 Dec 22-29;98(25):2800-4 PMID: 9860779
Age-dependent impairment of angiogenesis.
Circulation. 1999 Jan 5-12;99(1):111-20 PMID: 9884387
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.
Am J Pathol. 1999 Feb;154(2):355-63 PMID: 10027394
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
Nat Med. 1999 Apr;5(4):434-8 PMID: 10202935
Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner.
J Biol Chem. 1999 Jun 4;274(23):16349-54 PMID: 10347193
Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies.
Development. 1988 Mar;102(3):471-8 PMID: 2460305

Article Info

Journal

The Journal of clinical investigation

Abbr.

J Clin Invest

ISSN

0021-9738

DOI

10.1172/JCI6889

[email protected]

Published

1999-05-00

Pages

1231-6

Language

English

Region

United States

NLM ID

7802877

PMCID

PMC408362

Subset

External Links

PubMed source DOI: 10.1172/JCI6889 PMC Full Text View journal details

Analysis Services

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Contact

WeChat Official Account